Skip to content

Multicenter prospective observational study of repeat endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions: REPANC STUDY

Multicenter prospective observational study of repeat endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions: REPANC STUDY - The usefulness of repeat endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions: REPANC STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053831
Enrollment
115
Registered
2024-04-01
Start date
2024-02-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid pancreatic lesions

Interventions

None listed

Sponsors

Kyushu University
Lead Sponsor
Ehime University Oita University Osaka Medical and Pharmaceutical University Osaka Metropolitan University Okayama University Hospital Kagawa University Kansai Medical University Kansai Medical University Medical Center Kindai University Nagasaki University Hyogo Medical University Fukuoka University Wakayama Medical University Ehime Prefectural Central Hospital Oita San-ai Medical Center Osaka International Cancer Institute Osaka Red Cross Hospital Okanami General Hospital Kyu
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Over 20 years old 2. Patients with solid pancreatic lesions 3. Patients with performance status 2 or less 4. Patients requiring a re-puncture of EUS-TA for solid pancreatic lesions

Exclusion criteria

Exclusion criteria: 1. Patients with unsuitable for re-puncture of EUS-TA 2. Patients with performance status 4 3. Difficulty with transgastric or transduodenal puncture 4. Patients with severe organ dysfunction 5. Pregnant patients 6. Patients unable to get consent 7. Patients considered ineligible for this study

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy

Secondary

MeasureTime frame
1. Sensitivity and specificity 2. Feasibility of rapid cytological diagnosis 3. Factors associated with diagnostic difficulty cases 4. Adverse events 5. Technical success 6. Overall survival

Countries

Japan

Contacts

Public ContactAkiihsa Ohno

Kyushu University Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences

showa2644aki1aki2@yahoo.co.jp+81-92-642-5285

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026